Setterwalls advised Recipharm in connection with SEK 1 billion acquisition of Lusomedicameta

Setterwalls was the legal advisor for Recipharm AB (publ) in connection with the SEK 1 billion acquisition of Lusomedicameta Sociedade Técnica Farmacêutica S.A., a Lisbon based CDMO company. The equity consideration has been paid in a combination of cash and new issued shares.